Murray Christopher K.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
11
Insider Sells Sum
$1.66M

Insider Activity of Murray Christopher K.

According to the SEC Form 4 filings, Murray Christopher K., being in a position of

  1. CHIEF TECHNICAL OPERATIONS at Blueprint Medicines Corporation,
    оver the last 12 months, has bought 0 shares, and sold 8142 shares for $786,786,
    over all time since 2020-03-09, has bought 0 shares, and sold 21233 shares for $1.66M.

The largest sale of all time was on 2024-02-28 and amounted to 5000 shares of Blueprint Medicines Corporation for $500,000.

Biography of Murray Christopher K.

No biography is available at this moment.

2024-03-07SaleBlueprint Medicines Corporation
BPMC
CHIEF TECHNICAL OPERATIONS
2,521
0.0041%
$90.69$228,629+1.64%
2024-03-04SaleBlueprint Medicines Corporation
BPMC
CHIEF TECHNICAL OPERATIONS
621
0.001%
$93.65$58,157+2.76%
2024-02-28SaleBlueprint Medicines Corporation
BPMC
CHIEF TECHNICAL OPERATIONS
5,000
0.0086%
$100.00$500,000-2.23%
2023-12-07SaleBlueprint Medicines Corporation
BPMC
CHIEF TECHNICAL OPERATIONS
5,000
0.0084%
$75.00$375,000+24.17%
2023-12-04SaleBlueprint Medicines Corporation
BPMC
CHIEF TECHNICAL OPERATIONS
600
0.001%
$71.43$42,858+26.09%
2023-10-26SaleBlueprint Medicines Corporation
BPMC
CHIEF TECHNICAL OPERATIONS
600
0.001%
$56.40$33,840+62.77%
2023-03-06SaleBlueprint Medicines Corporation
BPMC
1,875
0.0033%
$45.68$85,641+32.68%
2022-08-04SaleBlueprint Medicines Corporation
BPMC
SVP, TECHNICAL OPERATIONS
2,500
0.0042%
$65.00$162,500-22.95%
2022-03-03SaleBlueprint Medicines Corporation
BPMC
SVP, TECHNICAL OPERATIONS
502
0.0008%
$56.19$28,207-8.24%
2021-03-04SaleBlueprint Medicines Corporation
BPMC
SVP, Technical Operations
1,210
0.002%
$86.76$104,984+2.9%
2020-03-09SaleBlueprint Medicines Corporation
BPMC
SVP, Technical Operations
804
0.0014%
$51.94$41,760+44.05%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.